164 related articles for article (PubMed ID: 2502560)
1. Amount, avidity, and specificity of antibodies to Pseudomonas aeruginosa in normal human sera.
Grzybowski J; Trafny EA; Wrembel-Wargocka J; Patzer J; Dzierzanowska D; Zawistowska-Marciniak I; Kłos M
J Clin Microbiol; 1989 Jun; 27(6):1367-71. PubMed ID: 2502560
[TBL] [Abstract][Full Text] [Related]
2. Characterization of antibody response to Pseudomonas aeruginosa in patients with wound infections.
Trafny EA; Grzybowski J; Patzer J; Popiel D; Wrembel-Wargocka J; Dzierzanowska D; Zawistowska-Marciniak I; Kobus K
Microbiol Immunol; 1991; 35(6):435-42. PubMed ID: 1921760
[TBL] [Abstract][Full Text] [Related]
3. [Production of an diagnostic erythrocyte agent from Pseudomonas aeruginosa exotoxin A].
Egizova SA; Deriabin PN; Karal'nik BV; Kanapina ASh; Moroz AF
Zh Mikrobiol Epidemiol Immunobiol; 1988 Dec; (12):38-41. PubMed ID: 3149841
[TBL] [Abstract][Full Text] [Related]
4. Antibody titers in serum of diffuse panbronchiolitis patients administered a multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase and exotoxin A and a common protective antigen (OEP).
Yamamoto M; Kubota Y; Matsuura M; Homma JY
Kitasato Arch Exp Med; 1988 Sep; 61(2-3):127-35. PubMed ID: 3145352
[No Abstract] [Full Text] [Related]
5. Therapy of experimental Pseudomonas burn wound sepsis with ciprofloxacin and Pseudomonas immune globulin.
Collins MS; Tsay GC; Hector RF; Roby RE; Dorsey JH
Antibiot Chemother (1971); 1987; 39():222-32. PubMed ID: 3118784
[No Abstract] [Full Text] [Related]
6. Identification of a small epitope in domain Ib of Pseudomonas aeruginosa exotoxin A that elicits enzyme-neutralizing antibodies.
Rutault K; Coin D; Vacheron MJ; Guinand M; Wallach J; Michel G
FEMS Microbiol Immunol; 1992 Jul; 4(5):267-72. PubMed ID: 1381199
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.
Hollsing AE; Granström M; Vasil ML; Wretlind B; Strandvik B
J Clin Microbiol; 1987 Oct; 25(10):1868-74. PubMed ID: 3117842
[TBL] [Abstract][Full Text] [Related]
8. A macromolecular structure produced by Pseudomonas aeruginosa is recognized by antibody to exotoxin A.
Klinger KW; Shuster CW
Infect Immun; 1984 Mar; 43(3):912-9. PubMed ID: 6421741
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-linked immunosorbent assay for detection of antibodies to Pseudomonas aeruginosa exoproteins.
Granström M; Wretlind B; Markman B; Pavlovskis OR; Vasil ML
Eur J Clin Microbiol; 1985 Apr; 4(2):197-200. PubMed ID: 3924608
[TBL] [Abstract][Full Text] [Related]
10. Serum antibody concentrations of cytotoxin, exotoxin, A, lipopolysaccharide, protease, and elastase and survival of patients with Pseudomonas aeruginosa bacteremia.
Baltch AL; Franke M; Smith RP; Asperilla M; Griffin P; Michelsen P; Lutz F
Clin Infect Dis; 1996 Nov; 23(5):1109-16. PubMed ID: 8922810
[TBL] [Abstract][Full Text] [Related]
11. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP). Application in patients with diffuse panbronchiolitis.
Homma JY; Tanimoto H
Antibiot Chemother (1971); 1987; 39():215-21. PubMed ID: 3118783
[No Abstract] [Full Text] [Related]
12. Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A.
Klinger KW; Shuster CW; Klinger J
Eur J Clin Microbiol; 1985 Apr; 4(2):201-6. PubMed ID: 3924609
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of serum antibody responses to Pseudomonas aeruginosa exotoxin A by cystic fibrosis and intensive care unit patients.
Cukor G; Blacklow NR; Nowak NA; Rich CM; Braverman LE; Fischer RA
J Clin Microbiol; 1983 Sep; 18(3):457-62. PubMed ID: 6415090
[TBL] [Abstract][Full Text] [Related]
14. Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients.
Jagger KS; Robinson DL; Franz MN; Warren RL
J Clin Microbiol; 1982 Jun; 15(6):1054-8. PubMed ID: 6809785
[TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa antibody detection in cystic fibrosis patients.
Trancassini M; De Vito D; Quattrucci S; Cipriani P
New Microbiol; 1999 Apr; 22(2):85-9. PubMed ID: 10322606
[TBL] [Abstract][Full Text] [Related]
16. [Protective polysaccharide-protein artificial antigens from O-specific polysaccharides of Pseudomonas aeruginosa and its exotoxin A].
Dmitriev BA; Kul'shin VA; Antsiferova NG; Vovk VA; Moroz AF
Dokl Akad Nauk SSSR; 1988; 298(5):1277-80. PubMed ID: 2454182
[No Abstract] [Full Text] [Related]
17. A Pseudomonas aeruginosa alginate-exotoxin A conjugate that elicits anti-alginate and exotoxin A-neutralizing antibodies.
Coin D; Vacheron MJ; Guinand M; Michel G
FEMS Microbiol Immunol; 1991 Aug; 3(4):185-92. PubMed ID: 1931130
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of IgG subclasses specific for Pseudomonas aeruginosa exoenzyme and polysaccharide antigens in chronically infected patients with cystic fibrosis.
Albus A; Saalmann M; Tesch H; Pedersen SS; Döring G
APMIS; 1989 Dec; 97(12):1146-8. PubMed ID: 2482060
[TBL] [Abstract][Full Text] [Related]
19. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. III. Polyvalent serum against three mucoid immunotypes potentiates phagocytosis of all (7) mucoid immunotypes.
Gościniak G; Grzybek-Hryncewicz K
Arch Immunol Ther Exp (Warsz); 1988; 36(2):195-203. PubMed ID: 3149178
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the specificity of lipopolysaccharide antigens from seven Fisher's immunotypes of Pseudomonas aeruginosa, using ELISA technique.
Trafny EA; Grzybowski J
Acta Microbiol Pol; 1988; 37(2):191-204. PubMed ID: 2467530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
